EUVIMEDEUVIMED entdecken
Kohortenstudie

Vomiting after intrathecal chemotherapy under anesthesia in pediatric patients with hematologic cancers: A cohort study

Gustavo Henrique França de Moraes iD, Luciana Cavalcanti Lima iD, Tania Cursino de Menezes Couceiro, Mecneide Mendes Lins iD, Débora de Oliveira Cumino iD, Leonardo Augusto Barbosa Magalhães Simões iD, Maria Júlia Gonçalves de Mello iD

Pediatric Anesthesia · 2024

DOI: 10.1111/pan.14756 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Pediatric Anesthesia, 2024. Verfasst von Gustavo Henrique França de Moraes und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Instituto de Medicina Integral Prof. Fernando Figueira, Recife, Brazil. Hauptthemen laut MEDLINE: Antiemetics, Anesthesia, Hematologic Neoplasms, Neoplasms. Die Arbeit nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Despite preventive strategies, vomiting is an adverse event affecting patients with cancer. However, literature on the incidence and risk factors for vomiting in pediatric patients with cancer are scarce.

Aim

To assess the incidence and risk factors for vomiting within 24 h and goodness of fit for the Eberhart score in pediatric patients with hematologic cancers after receiving intrathecal chemotherapy under deep sedation.

Methods

This prospective cohort study included patients under 20 years of age with hematologic cancers who were scheduled to undergo intrathecal chemotherapy under anesthesia. The primary outcome was the occurrence of vomiting within 24 h after the end of anesthesia. Sociodemographic and procedure data and underlying diseases were collected. Patients were monitored during the procedure, in the postanesthesia care unit, and the day after (by phone call).

Results

A total of 139 patients were included, and the incidence of vomiting was 30.9% within 24 h after intrathecal chemotherapy under anesthesia, with 90.7% of vomiting prior to 6 h. Prophylactic ondansetron was administered prior to the procedure to 45.3% of patients. Risk factors for vomiting were female gender (hazard ratio: 2.47, 95% confidence interval: 1.35–4.53, p : .003), consolidation phase of treatment (hazard ratio: 2.16, 95% confidence interval: 1.10–4.24, p : .025), and history of kinetosis (hazard ratio: 2.49, 95% confidence interval: 1.31–4.70, p : .005). Incidence of vomit was higher than estimated by the Eberhart score distribution (observed incidence in patients with a score of zero: 33.3%; with a score of one: 28.8%; with a score of two: 60%).

Conclusion

A high incidence of vomiting was observed within 24 h after intrathecal chemotherapy under propofol deep sedation. Risk factors for this outcome were established (being female, consolidation phase of treatment, and previous kinetosis), and evidence suggested that the Eberhart score was not suitable for the studied population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntiemeticsAnesthesiaHematologic NeoplasmsNeoplasmsHumansChildFemaleMaleCohort StudiesProspective StudiesVomitingOndansetronDouble-Blind Method

Stichwörter der Autor:innen

anesthesianeoplasmspediatricspostoperative nausea and vomitingvomiting

Substanzen

AntiemeticsOndansetron

Autor:innen und Institutionen

  • Department of Anesthesiology, Instituto de Medicina Integral Prof. Fernando Figueira, Recife, Brazil.
  • Department of Pediatric Anesthesiology, Instituto de Medicina Integral Prof. Fernando Figueira, Recife, Brazil.
  • Faculdade Pernambucana de Saúde, Recife, Brazil.
  • Pediatric Oncology Unit, Instituto de Medicina Integral Prof. Fernando Figueira, Recife, Brazil.
  • Department of Pediatric Anesthesiology, Hospital Infantil Sabará, São Paulo, Brazil.
  • Post Graduate and Research Department, Instituto de Medicina Integral Prof. Fernando Figueira, Recife, Brazil.

ORCID-Profile: Gustavo Henrique França de Moraes, Luciana Cavalcanti Lima, Mecneide Mendes Lins, Débora de Oliveira Cumino, Leonardo Augusto Barbosa Magalhães Simões, Maria Júlia Gonçalves de Mello

Zitieren

APA

França de Moraes, G. H., Lima, L. C., Couceiro, T. C. M., Lins, M. M., Cumino, D. O., Simões, L. A. B. M., & Mello, M. J. G. (2024). Vomiting after intrathecal chemotherapy under anesthesia in pediatric patients with hematologic cancers: A cohort study. Pediatric Anesthesia. https://doi.org/10.1111/pan.14756

Vancouver

França de Moraes GH, Lima LC, Couceiro TCM, Lins MM, Cumino DO, Simões LABM, et al. Vomiting after intrathecal chemotherapy under anesthesia in pediatric patients with hematologic cancers: A cohort study. Pediatric Anesthesia. 2024. doi:10.1111/pan.14756

BibTeX
@article{FranadeMoraes2024,
  author = {França de Moraes, Gustavo Henrique and Lima, Luciana Cavalcanti and Couceiro, Tania Cursino de Menezes and Lins, Mecneide Mendes and Cumino, Débora de Oliveira and Simões, Leonardo Augusto Barbosa Magalhães and Mello, Maria Júlia Gonçalves de},
  title = {Vomiting after intrathecal chemotherapy under anesthesia in pediatric patients with hematologic cancers: A cohort study},
  journal = {Pediatric Anesthesia},
  year = {2024},
  doi = {10.1111/pan.14756}
}
Kostenlos starten →